ArticleFrontiers in drug safety and regulation2026
Psychotropic dispensing in Greek adolescents and young adults: national trends and regional variation.
Article in Frontiers in drug safety and regulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The study quantified national trends in psychotropic medication dispensing among children and adolescents (0-17 years) and young adults (18-29 years) in Greece during 2020-2024 and characterized patterns by drug class, sex, diagnosis, and region. Methods: Repeated cross-sectional analyses used nationwide administrative e-prescription dispensing data (used as a proxy for medication exposure) aggregated by year, age group, and sex. Outcomes were total dispensed packs, dispensing prevalence per 1,000 inhabitants, and dispensing intensity (packs per patient). Pharmacologic classes followed Anatomical Therapeutic Chemical (ATC) groupings, while International Classification of Diseases, 10th Revision (ICD-10) macro-groups were constructed to link dispensing with psychiatric and selected G-chapter and related diagnostic categories. Results: Overall psychotropic dispensing prevalence increased from 64.5 to 71.8 per 1,000 inhabitants between 2020 and 2024. SSRI dispensing prevalence increased from 6.65 to 9.09 per 1,000, whereas hypnotic benzodiazepine prevalence declined from 1.01 to 0.94 per 1,000 and Z-drugs prevalence decreased from 0.20 to 0.15 per 1,000. Females had higher odds of antidepressant dispensing. Regional antidepressant dispensing prevalence was highest in the Ionian Islands (13.46 per 1,000), followed by Attica (11.93 per 1,000) and Western Greece (11.86 per 1,000). Conclusion: Psychotropic medication dispensing among Greek adolescents and young adults increased during 2020-2024, largely due to SSRIs, with stable dispensing intensity and marked heterogeneity by age, sex, diagnosis, and region. These findings support age-appropriate prescribing stewardship and targeted regional monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.